Aquestive Therapeutics, Inc.
NASDAQ:AQST
4.99 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13.542 | 20.099 | 12.053 | 13.206 | 13.002 | 13.241 | 11.134 | 10.682 | 11.463 | 13.265 | 12.27 | 11.078 | 13.287 | 15.345 | 11.122 | 7.149 | 8.26 | 21.675 | 8.765 | 16.419 | 12.418 | 11.129 | 12.643 | 16.824 | 13.267 | 13.928 | 23.411 | 12.195 | 27.146 | 11.142 | 16.436 |
| Cost of Revenue
| 4.437 | 4.526 | 4.389 | 4.679 | 4.798 | 6.617 | 4.737 | 5.305 | 4.625 | 5.242 | 4.214 | 3.366 | 4.4 | 4.466 | 2.757 | 2.788 | 2.978 | 3.539 | 3.659 | 6.792 | 4.643 | 5.42 | 3.506 | 4.787 | 5.592 | 4.973 | 5.636 | 5.615 | 4.88 | 5.141 | 4.184 |
| Gross Profit
| 9.105 | 15.573 | 7.664 | 8.527 | 8.204 | 6.624 | 6.397 | 5.377 | 6.838 | 8.023 | 8.056 | 7.712 | 8.887 | 10.879 | 8.365 | 4.361 | 5.282 | 18.136 | 5.106 | 9.627 | 7.775 | 5.709 | 9.137 | 12.037 | 7.675 | 8.955 | 17.775 | 6.58 | 22.266 | 6.001 | 12.252 |
| Gross Profit Ratio
| 0.672 | 0.775 | 0.636 | 0.646 | 0.631 | 0.5 | 0.575 | 0.503 | 0.597 | 0.605 | 0.657 | 0.696 | 0.669 | 0.709 | 0.752 | 0.61 | 0.639 | 0.837 | 0.583 | 0.586 | 0.626 | 0.513 | 0.723 | 0.715 | 0.579 | 0.643 | 0.759 | 0.54 | 0.82 | 0.539 | 0.745 |
| Reseach & Development Expenses
| 5.269 | 4.162 | 5.932 | 2.888 | 3.196 | 3.473 | 3.547 | 4.278 | 3.232 | 5.198 | 4.773 | 4.4 | 4.726 | 4.262 | 3.659 | 4.425 | 7.26 | 3.847 | 4.354 | 3.057 | 5.063 | 8.151 | 4.303 | 5.683 | 4.534 | 7.994 | 4.901 | 6.271 | 5.684 | 4.837 | 5.343 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.613 | 0 | 0 | 14.613 | 16.474 | 13.714 | 16.246 | 17.908 | 18.703 | 12.345 | 33.647 | 7.569 | 7.565 | 6.161 | 5.223 | 6.128 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.969 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.126 | 11.356 | 10.689 | 9.55 | 7.385 | 7.36 | 7.455 | 11.812 | 12.459 | 15.587 | 13.021 | 14.981 | 12.129 | 13.134 | 13.231 | 15.582 | 11.803 | 13.894 | 14.613 | 16.474 | 13.714 | 16.246 | 17.908 | 18.703 | 12.345 | 33.647 | 7.569 | 7.565 | 6.161 | 5.223 | 6.128 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.007 | -0.001 | -0.021 | 0.024 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 17.395 | 15.518 | 16.621 | 12.438 | 10.581 | 10.833 | 11.002 | 16.09 | 15.691 | 20.785 | 17.794 | 19.381 | 16.855 | 17.396 | 16.89 | 20.007 | 19.063 | 17.741 | 18.967 | 19.531 | 18.777 | 24.397 | 22.211 | 24.386 | 16.879 | 41.641 | 12.47 | 13.836 | 11.845 | 10.06 | 11.471 |
| Operating Income
| -8.29 | 0.055 | -8.957 | -3.911 | -2.377 | -4.209 | 9.583 | -10.713 | -8.853 | -12.762 | -9.738 | -11.669 | -7.968 | -6.517 | -8.525 | -15.646 | -13.781 | 0.395 | -13.861 | -9.904 | -11.002 | -18.688 | -13.074 | -12.349 | -9.204 | -32.686 | 5.305 | -7.256 | 10.421 | -4.059 | 0.781 |
| Operating Income Ratio
| -0.612 | 0.003 | -0.743 | -0.296 | -0.183 | -0.318 | 0.861 | -1.003 | -0.772 | -0.962 | -0.794 | -1.053 | -0.6 | -0.425 | -0.766 | -2.189 | -1.668 | 0.018 | -1.581 | -0.603 | -0.886 | -1.679 | -1.034 | -0.734 | -0.694 | -2.347 | 0.227 | -0.595 | 0.384 | -0.364 | 0.048 |
| Total Other Income Expenses Net
| -3.219 | -2.8 | -3.871 | -4.099 | 0.202 | -1.299 | -1.515 | -1.639 | -3.683 | -3.54 | -3.482 | -13.822 | -6.587 | -5.85 | -6.147 | -4.722 | -2.77 | -2.729 | -2.669 | -2.732 | -4.896 | -1.784 | -1.652 | -0.007 | -4.117 | -1.88 | 0.721 | -0.814 | -1.97 | 0.111 | -0.42 |
| Income Before Tax
| -11.509 | -2.745 | -12.828 | -8.01 | -2.175 | -5.508 | 8.068 | -12.352 | -12.536 | -16.302 | -13.22 | -28.945 | -14.555 | -12.367 | -14.672 | -20.368 | -16.551 | -2.334 | -16.53 | -12.636 | -18.412 | -20.472 | -14.726 | -13.944 | -15.038 | -36.493 | 4.099 | -10.04 | 8.451 | -5.897 | -1.457 |
| Income Before Tax Ratio
| -0.85 | -0.137 | -1.064 | -0.607 | -0.167 | -0.416 | 0.725 | -1.156 | -1.094 | -1.229 | -1.077 | -2.613 | -1.095 | -0.806 | -1.319 | -2.849 | -2.004 | -0.108 | -1.886 | -0.77 | -1.483 | -1.84 | -1.165 | -0.829 | -1.133 | -2.62 | 0.175 | -0.823 | 0.311 | -0.529 | -0.089 |
| Income Tax Expense
| -11.509 | 0 | 0.164 | 0.101 | -0.14 | 0.284 | -11.238 | 5.797 | 0.005 | 3.54 | 3.482 | 19.02 | -0.001 | 0.373 | -0.001 | -1.102 | 0.008 | 0.018 | 0.102 | -0.652 | 2.652 | 0.153 | -0.475 | 1.135 | 1.932 | 1.129 | 1.951 | 1.97 | 0 | 1.949 | 1.818 |
| Net Income
| -11.509 | -2.745 | -12.828 | -8.111 | -2.035 | -5.792 | 19.306 | -18.149 | -12.536 | -19.842 | -16.702 | -28.945 | -14.555 | -12.367 | -14.672 | -20.368 | -16.551 | -2.334 | -16.53 | -12.636 | -18.412 | -20.472 | -14.726 | -13.944 | -15.038 | -36.493 | 4.099 | -10.04 | 8.451 | -5.897 | -1.457 |
| Net Income Ratio
| -0.85 | -0.137 | -1.064 | -0.614 | -0.157 | -0.437 | 1.734 | -1.699 | -1.094 | -1.496 | -1.361 | -2.613 | -1.095 | -0.806 | -1.319 | -2.849 | -2.004 | -0.108 | -1.886 | -0.77 | -1.483 | -1.84 | -1.165 | -0.829 | -1.133 | -2.62 | 0.175 | -0.823 | 0.311 | -0.529 | -0.089 |
| EPS
| -0.13 | -0.03 | -0.17 | -0.12 | -0.032 | -0.1 | 0.35 | -0.33 | -0.23 | -0.44 | -0.4 | -0.72 | -0.37 | -0.33 | -0.41 | -0.6 | -0.49 | -0.07 | -0.49 | -0.48 | -0.74 | -0.82 | -0.59 | -0.56 | -0.64 | -1.52 | 0.2 | -0.5 | 0.39 | -0.29 | -0.073 |
| EPS Diluted
| -0.13 | -0.03 | -0.17 | -0.12 | -0.032 | -0.1 | 0.26 | -0.33 | -0.23 | -0.44 | -0.4 | -0.72 | -0.37 | -0.33 | -0.41 | -0.6 | -0.49 | -0.07 | -0.49 | -0.48 | -0.74 | -0.82 | -0.59 | -0.56 | -0.64 | -1.52 | 0.2 | -0.5 | 0.39 | -0.29 | -0.073 |
| EBITDA
| -8.29 | 0.26 | -8.75 | -3.444 | -2.377 | -3.791 | 9.908 | -10.648 | -8.252 | -12.063 | -9.011 | -11.534 | -7.232 | -5.402 | -7.77 | -15.642 | -13.12 | 1.21 | -12.872 | -9.833 | -10.155 | -17.811 | -12.8 | -12.042 | -8.243 | -32.707 | 6.282 | -6.289 | 11.378 | -3.11 | 1.709 |
| EBITDA Ratio
| -0.612 | 0.013 | -0.726 | -0.261 | -0.183 | -0.286 | 0.89 | -0.997 | -0.72 | -0.909 | -0.734 | -1.041 | -0.544 | -0.352 | -0.699 | -2.188 | -1.588 | 0.056 | -1.469 | -0.599 | -0.818 | -1.6 | -1.012 | -0.716 | -0.621 | -2.348 | 0.268 | -0.516 | 0.419 | -0.279 | 0.104 |